Big Move For Evofem Biosciences, Inc.
Wed, Jan 19, 2022 at 05:35 PM
Evofem Biosciences, Inc. (EVFM:NASDAQ) soared at $0.49, a gain of 22.9%. The stock appeared on our News Catalysts scanner on Wed, Jan 12, 2022 at 07:27 AM in the 'BIOTECH' category. From Wed, Jan 05, 2022, the stock recorded 50.00% Up Days and 33.33% Green Days
The stock spiked on Wed, Jan 12, 2022 at $0.54 with a volume of 54M+, and its share price has been moving sideways in recent weeks.
About Evofem Biosciences, Inc. (EVFM:NASDAQ)
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Top 10 Gainers:
- Zogenix, Inc. (ZGNX:NASDAQ), 65.73%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 45.37%
- Valneva SE (VALN:NASDAQ), 45.01%
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 41.1%
- ShiftPixy, Inc. (PIXY:NASDAQ), 31.5%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 22.86%
- Gamida Cell Ltd. (GMDA:NASDAQ), 22.52%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 22.03%
- Muscle Maker, Inc. (GRIL:NASDAQ), 21.64%
- Platinum Group Metals Ltd. (PLG:NYSEMKT), 20.73%